Close
ACHEMA MIDDLE EAST 2026

Jinan Asia Pharmaceutical Opens US Branch

AI Summary

Jinan Asia Pharmaceutical (JAP) opened an office in Irvine, California and introduced the newly formed HL-Pharma USA Corporation. JAP is one of the global leaders in producing Choline, Betaine and their derivatives. HL-Pharma, located in Irvine California, will act as JAP’s exclusive U.S. representative North America.

According to the U.S. Customs Department, over 800 metric tons of Choline was imported into the U.S. in 2013, of which JAP enjoyed greater than a 30 percent market share.

Earlier this year, JAP signed an exclusive partnership with GWI.

The pharmaceutical industry rarely announces its most significant shifts loudly. The signals are there — if you know where to look.

The Pharma Advancement briefing is how the sector’s most informed professionals stay ahead of those signals — covering drug development, regulatory affairs, manufacturing, and market access across every major region.

  • The stories pharmaceutical professionals will be discussing tomorrow, in your inbox today
  • Analysis that goes beyond the headline — written for readers who already understand the industry
  • The briefing that the sector’s most informed professionals open first

SUBSCRIBE OUR NEWSLETTER

WHITE PAPERS

RELATED ARTICLES